Related Experiment Video
Updated: Jan 31, 2026

07:07
Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT
Published on: May 2, 2017
14.4K
Gastric Ulcer Mimicking Malignancy on FDG PET/CT
Shumao Zhang, Fuqiang Shao1, Yue Chen
1Department of Nuclear Medicine, Zigong First People's Hospital, Zigong, Sichuan.
Clinical Nuclear Medicine
|January 5, 2019
Summary
F-FDG PET/CT staging for cervical cancer revealed unexpected gastric findings. A hypermetabolic lesion, initially suspicious for malignancy, was confirmed as a benign gastric ulcer.
Area of Science:
- Oncology
- Nuclear Medicine
- Gastroenterology
Background:
- Cervical cancer staging often involves F-FDG PET/CT to assess disease extent and lymph node involvement.
- Fluorine-18 fluorodeoxyglucose (F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) is a key imaging modality in oncologic staging.
- Gastric lesions can present with variable F-FDG uptake, sometimes mimicking malignancy.
Observation:
- A 52-year-old woman with newly diagnosed cervical carcinoma underwent F-FDG PET/CT for staging.
- The PET/CT demonstrated known cervical carcinoma and enlarged, hypermetabolic lymph nodes.
- An additional focus of intense F-FDG activity was noted in the gastric antrum.
Findings:
- The hypermetabolic gastric antrum lesion was biopsied and confirmed as a gastric ulcer.
- The patient's cervical cancer was staged appropriately, with incidental identification of the gastric pathology.
- The gastric ulcer responded successfully to antiulcer treatment.
Implications:
- F-FDG PET/CT can identify unexpected findings outside the primary cancer site, requiring careful interpretation.
- Hypermetabolic activity in the stomach on F-FDG PET/CT does not always indicate malignancy; benign conditions like ulcers can show increased uptake.
- This case highlights the importance of integrating imaging findings with clinical information and biopsy results for accurate diagnosis and management.
Related Concept Videos
Gastric Motility
3.1K
Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
3.1K
Gastric Emptying
3.7K
Gastric emptying occurs when the stomach gradually releases chyme into the duodenum. When the stomach is distended, it triggers the release of gastrin, a hormone that promotes gastric acid secretion to aid in digestion. Additionally, stomach distension contributes to peristaltic waves that propel gastric contents toward the pyloric region. The gastroenteric reflex, on the other hand, primarily stimulates peristalsis in the intestines, facilitating the movement of contents further along the...
3.7K
Gastric Phase of Digestion
3.4K
The gastric phase of digestion begins as soon as food enters the stomach. The incoming food bolus triggers neural and hormonal mechanisms, which last approximately 3 to 4 hours. During this phase, the stomach undergoes significant changes to prepare the food for further digestion and absorption.
When food enters the stomach, it stretches the stomach walls and activates stretch receptors. This triggers local reflexes of the enteric nervous system, mediated through the myenteric plexus. These...
When food enters the stomach, it stretches the stomach walls and activates stretch receptors. This triggers local reflexes of the enteric nervous system, mediated through the myenteric plexus. These...
3.4K
Peptic Ulcer Disease II: Pathophysiology
2.1K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.1K
Peptic Ulcer Disease I: Introduction
824
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
824
Peptic Ulcer Disease IV: Management
493
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
493

